The European Commission cleared the path on July 23, 2026, ruling that the Saudi-led, $55 billion buyout of Electronic Arts “would not raise competition concerns.” For EA as a whole, that is one more box checked on the road to closing the largest leveraged buyout in history. For BioWare, the Edmonton studio behind Mass Effect and Dragon Age, it is something closer to a verdict. The RPG maker has shrunk from more than 400 staff at its peak to fewer than 100 today, and its entire remaining output now rides on a single unannounced project widely referred to as Mass Effect 5. This is a full analysis of what the EU’s antitrust clearance means for BioWare specifically, how the studio got this small, and what has to go right for it to still exist in its current form a year from now.

BioWare is not a random footnote in the EA buyout story. It is the test case. Of all the studios inside Electronic Arts, none illustrates the tension between the new owners’ $20 billion debt load and the cost of keeping a prestige single-player studio alive better than the maker of Baldur’s Gate, Knights of the Old Republic, and Mass Effect. Every regulatory milestone that brings the deal closer to closing brings BioWare’s fans closer to an answer they have been dreading since the acquisition was announced.

EU Antitrust Approval Clears a Major Hurdle for the $55 Billion EA Buyout

The European Commission’s July 23 decision found that the deal’s “limited impact on competition in the markets where the companies are active” – PC, console, and mobile game production and distribution, plus esports events – did not warrant a Phase 2 investigation. It is a standard merger-control clearance, not a verdict on the buyout’s broader consequences, but it removes one of the last scheduled checkpoints standing between the consortium and full ownership of EA, according to Engadget’s reporting on the EU approval.

The buyer group – Saudi Arabia’s Public Investment Fund (PIF), private equity firm Silver Lake, and Jared Kushner’s Affinity Partners – would own roughly 93.4%, 5.5%, and 1.1% of EA respectively once the deal closes, per Wolf’s Gaming Blog’s breakdown of the July 23 clearance. That is not the finish line. A second, separate EU review under the bloc’s Foreign Subsidies Regulation is due by July 30, 2026, and the US Committee on Foreign Investment (CFIUS) – the review that already forced the deal past its original June 30 outside date – now runs to September 28. But antitrust clearance was the review most likely to surface a “no,” and it came back a “yes.” For a company the size of EA, that is genuinely good news. For BioWare, a nearly 100-person studio inside a business about to carry $20 billion in new debt, it starts a different clock.

BioWare by the Numbers: A Studio in Freefall

The scale of BioWare’s contraction is easiest to see laid out year by year. The studio that once ran three offices and shipped one of the best-selling RPG franchises in the industry now fits in a single open-plan floor. The table below tracks the headline numbers from BioWare’s commercial peak to its current headcount.

YearEventFigure
2007EA acquires BioWare3 studios (Edmonton, Austin, Montreal)
2009Dragon Age: Origins ships3.2 million copies in 3 months
2011Dragon Age II ships1 million copies in 2 weeks
2014Dragon Age: Inquisition ships12M+ lifetime (studio’s best-seller)
2019Anthem launchesCritical and commercial failure
2021“Anthem NEXT” relaunch canceledMulti-year overhaul abandoned
Oct 2024Dragon Age: The Veilguard shipsSales ~50% below EA’s internal target
Jan 2025EA restructures BioWare100+ staff cut
Jan 12, 2026Anthem servers shut downService officially ended
Jul 2026Current headcountFewer than 100 employees

Peak headcount across BioWare’s three studios topped 400. By the time Dragon Age: The Veilguard shipped in October 2024, that number had already fallen below 200. The January 2025 restructuring, which cut more than 100 additional roles, is what pushed BioWare under the 100-employee mark it sits at today – a reduction achieved through a mix of direct layoffs and reassignment of staff to other EA projects, not layoffs alone.

From 400 Staff to Fewer Than 100: Inside BioWare’s Collapse

BioWare’s decline did not happen in a single event. It is the compounding result of two consecutive commercial disappointments a studio of its size could not fully absorb. Anthem, released in February 2019, was meant to be BioWare’s answer to the live-service shooter boom kicked off by Destiny. It launched to poor reviews and a player base that evaporated within weeks. EA and BioWare spent two years attempting a full relaunch under the internal codename “Anthem NEXT” before quietly abandoning the effort in February 2021. The game limped on as a skeleton service until EA confirmed it would sunset entirely in July 2025, with servers going dark for good on January 12, 2026 – closing the book on a project that consumed years of the studio’s resources for a return that never materialized.

Layoffs, Reassignment, and What EA Won’t Say

EA has never published a detailed breakdown of exactly how many BioWare positions were eliminated versus reassigned elsewhere in the company, and the publisher does not break out individual studio headcounts in its public filings. What is confirmed, via reporting cross-cited by Notebookcheck’s coverage of BioWare’s uncertain future, is the outcome: a studio that employed 200-plus people while finishing its last shipped game is now under 100, with effectively its entire remaining staff assigned to one project. That concentration is unusual even by the standards of an industry that has cut tens of thousands of jobs since 2023 – most contracting studios still maintain multiple concurrent projects as a hedge. BioWare no longer has that luxury.

Dragon Age: The Veilguard’s Sales Miss Sealed BioWare’s Fate

If Anthem was the wound, Dragon Age: The Veilguard was the complication that made it fatal. Released October 31, 2024, after roughly a decade of troubled development spanning multiple creative pivots, the game arrived to generally positive reviews but tepid commercial performance. EA’s own financial disclosures put sales at approximately 50% below the company’s internal expectations. The most-cited independent estimate puts lifetime sales under 1.5 million copies – a fraction of the 12 million-plus that 2014’s Dragon Age: Inquisition sold over its lifetime, and nowhere near enough to justify a franchise-scale budget. Game director Corinne Busche, an 18-year EA veteran, left the company roughly three months after launch.

For a studio that had already burned years and headcount on Anthem’s failed relaunch, a second consecutive miss removed any cushion BioWare had left. GamesRadar+’s reporting on fan reaction to the buyout captures the mood among longtime players bluntly: after Anthem and Veilguard, there is no goodwill left to draw on if the next project stumbles too. That is the backdrop against which the EA buyout’s $20 billion debt load lands on BioWare specifically – not as an abstract corporate-finance detail, but as pressure on the one project standing between the studio and closure.

Mass Effect 5: BioWare’s Make-or-Break Bet

Every remaining BioWare employee is now, in effect, working on one game. The next Mass Effect entry – commonly referred to as “Mass Effect 5,” an unofficial placeholder with no title EA has confirmed – has been in pre-production since early 2025. Former BioWare executive producer Mark Darrah said in January 2026 that “100% of what they’re working on is Mass Effect,” and executive producer Michael Gamble said in April 2026 that the team was still too early in development to show anything. Fans have waited roughly eight years since 2017’s Mass Effect: Andromeda for a new mainline entry in the series.

The stakes attached to that single project are difficult to overstate. BioWare has no other title in visible production, no announced live-service backup, and a headcount too small to run parallel projects even if it wanted to. If the next Mass Effect underperforms the way Anthem and Veilguard did, the studio would be entering its fourth consecutive commercial disappointment with a fraction of the staff it had for its third. If it succeeds, it would be the first genuine win BioWare has delivered since Inquisition in 2014 – over a decade earlier – and the clearest argument for keeping the studio intact under new, debt-conscious ownership. There is effectively no middle scenario where a modest performance buys BioWare the kind of patience it received after Dragon Age II underperformed in 2011.

Who’s Buying EA: PIF, Silver Lake and Affinity Partners

The consortium taking EA private is led by Saudi Arabia’s Public Investment Fund, joined by private equity firm Silver Lake and Jared Kushner’s Affinity Partners. Announced September 29, 2025 at $210 per share in an all-cash deal, the transaction is financed by roughly $36 billion in equity – including PIF rolling over its existing EA stake – and about $20 billion in debt fully committed by JPMorgan Chase, of which $18 billion is expected to be funded at close. EA shareholders approved the deal on December 22, 2025 with near-unanimous support. The table below summarizes where each piece of the approval process stands as of this week.

MilestoneStatusDate
Deal announcedCompleteSeptember 29, 2025
EA shareholder voteApproved (~99%)December 22, 2025
EU merger control (antitrust)Approved – no competition concernsJuly 23, 2026
EU Foreign Subsidies Regulation reviewDecision pendingDue July 30, 2026
CFIUS (US national security review)Outstanding – extended outside dateDue by September 28, 2026
Post-close ownershipPIF 93.4% / Silver Lake 5.5% / Affinity 1.1%Upon closing

PIF’s involvement in gaming extends well beyond EA. Its dedicated gaming and esports arm, Savvy Games Group, has allocated roughly $38 billion since 2022, owns ESL FACEIT Group (formed in a roughly $1.5 billion 2022 merger) and acquired mobile publisher Scopely for $4.9 billion in 2023. Notably, when PIF transferred around $12 billion of its directly-held gaming equity stakes – including positions in Nintendo, Take-Two, and Bandai Namco – into Savvy’s structure in early 2026, it left its EA stake outside that transfer, held directly by PIF instead. That is a structural signal that PIF treats EA as a strategic holding in its own right, not simply another line in a diversified gaming portfolio.

The $20 Billion Debt Question

Nothing about BioWare’s future can be separated from the mechanics of how this deal is funded. Roughly $20 billion of the $55 billion price tag is debt, arranged through JPMorgan Chase and landing on EA’s balance sheet the moment the transaction closes – a company that, as a public entity, has run essentially debt-free. Debt service on that scale requires sustained, predictable cash flow, and EA’s most reliable cash generators are its sports and live-service franchises, not narrative single-player RPGs with multi-year development cycles and uncertain commercial ceilings.

As GamesRadar+ reported, industry observers have warned that the debt load could translate into mass layoffs, more aggressive monetization, and broader cost-cutting across EA’s studio portfolio as the new ownership works to service its obligations. That is precisely the environment in which a sub-100-person studio with two consecutive underperforming releases and no secondary project is most exposed. A profitable public company can subsidize a prestige studio’s slow, expensive development cycle out of goodwill and long-term brand value. A newly leveraged private company answering to lenders has a much narrower window for patience.

Mark Darrah’s Warning: Sell, Close, or Cut

Few people outside EA’s current leadership have spoken as directly about BioWare’s odds as Mark Darrah, the studio’s former executive producer on the Dragon Age series and Anthem, who left the company in 2020 and now comments publicly on EA and BioWare matters. Darrah has argued it is “incredibly unlikely that EA stays exactly as it currently is in a private structure, especially carrying $20 billion worth of debt,” a view echoed by Yahoo Finance’s coverage of the shareholder vote and debt financing.

Darrah’s more specific point is about which lever gets pulled. Rather than outright closures, he has pointed to EA’s “huge repository of dormant IPs just sitting there,” suggesting that selling off studios or franchises could make more financial sense to new ownership than shutting them down and writing off the asset entirely. On PIF’s motivations, he has noted the fund is “very active in the sports area” and that “EA Sports makes a ton of sense” as a fit for that existing portfolio – an observation that implicitly puts narrative-focused studios like BioWare further from the new owners’ core strategic interest than EA’s sports and live-service franchises. None of this guarantees BioWare’s closure. It does suggest that BioWare’s survival as an EA-owned, internally-funded studio is not the only outcome on the table – a sale or spin-off of the Mass Effect and Dragon Age IP is a live possibility industry watchers are taking seriously.

What’s Left in the Regulatory Path to Closing

The EU antitrust clearance removes the review most likely to have produced a genuine roadblock. What remains is narrower but not yet finished.

EU Clears Merger Review, Foreign Subsidy Decision Due July 30

The July 23 decision was specifically a merger-control (antitrust) clearance under EU competition law. A second, separate EU process – a review under the bloc’s Foreign Subsidies Regulation, which screens whether foreign state support (relevant here given PIF’s sovereign status) distorts the EU market – carries its own deadline of July 30, 2026, according to Tech Times’ reporting on the EU subsidy review timeline. Both EU processes are widely expected to conclude in the deal’s favor. The real bottleneck remains CFIUS in the United States, which missed the transaction’s original June 30, 2026 outside date and now runs to September 28. Analysts have generally assessed a full CFIUS block as unlikely, with mitigation conditions – such as data-handling commitments or governance safeguards – seen as the more probable outcome. Some members of the US Congress have separately called for a Federal Trade Commission review of the deal.

BioWare vs EA’s Other Studios: A Tale of Two Fates

BioWare’s contraction is extreme, but it is not happening in isolation. The past year has been brutal across the games industry, and EA’s buyout-driven cost discipline is arriving on top of an already battered studio landscape. Microsoft cut roughly 3,200 Xbox jobs and divested four studios well before its own restructuring stabilized. id Software cut 136 of its 185 staff – a 74% reduction – even as it shipped a Doom expansion the very next day. Ubisoft’s stock has fallen 93% over seven years alongside a $1.4 billion loss, and Embracer Group split itself in two as profit craters 68%. Even Bungie, following a $200 million lawsuit settlement, watched its Marathon relaunch shed 92% of its player interest.

What sets BioWare apart within that pattern is concentration risk. Xbox, Ubisoft, and Embracer are all cutting from a much larger base and typically retain multiple projects across multiple studios, spreading the risk of any single release’s failure. BioWare has one project and, at current headcount, effectively no capacity to run a second. Where a bad quarter at a larger publisher shows up as a line-item writedown, a bad launch at BioWare’s current size would remove the studio’s only active product.

Three Decades of BioWare: From Baldur’s Gate to Buyout

BioWare was founded in 1995 in Edmonton, Alberta, by a group of doctors-turned-developers, and built its reputation on the choice-driven RPG format across Baldur’s Gate, Star Wars: Knights of the Old Republic, and the original Mass Effect trilogy. EA acquired the studio in 2007, and for the following decade BioWare was among the publisher’s most reliable prestige assets: Dragon Age: Origins sold 3.2 million copies in its first three months in 2009, Dragon Age II moved a million copies in two weeks in 2011 despite a mixed critical reception, and 2014’s Dragon Age: Inquisition – the studio’s commercial peak – went on to sell more than 12 million copies and swept major Game of the Year honors.

Everything shipped since Inquisition has undershot it. Mass Effect: Andromeda (2017) was a critical disappointment that effectively paused the Mass Effect series for eight years. Anthem (2019) burned years of the studio’s capacity on a live-service bet that never recovered. Dragon Age: The Veilguard (2024) posted BioWare’s most encouraging reviews in a decade but still landed roughly 50% below EA’s internal sales target. Measured against that three-decade arc, a studio with 400-plus staff and back-to-back double-digit-million sellers in the 2007-2014 stretch has become a sub-100-person team whose entire future rests on reversing a run of disappointment now in its second decade – all while its parent company takes on the largest leveraged buyout debt load in gaming history.

Market Impact: What Wall Street and Gamers Are Watching

For investors, BioWare’s fate is a rounding error against a $55 billion transaction – the studio’s headcount and budget are immaterial to a deal of this size, and none of the regulatory reviews governing the buyout mention BioWare by name. What Wall Street is actually pricing is CFIUS risk and the deal spread between EA’s trading price and the $210-per-share offer, alongside how quickly the new ownership can begin servicing $20 billion in debt once the transaction closes.

For the gaming audience, though, BioWare has become the buyout’s most closely watched bellwether for a different reason: it is the clearest, most human-scale test of what leveraged, debt-financed ownership means for the studios EA has spent two decades acquiring. A sports-and-live-service-heavy portfolio can service debt through predictable annual releases and microtransactions. A single-player RPG studio on a multi-year development cycle, with no live-service backup and a recent history of underperformance, cannot make the same case – and every player watching BioWare’s headcount is really asking what happens to every other prestige studio EA owns once the debt clock starts running.

Five Predictions for BioWare’s Next Chapter

  1. The EU’s Foreign Subsidies Regulation review clears by or shortly after July 30. Analysts widely expect approval, mirroring the antitrust outcome; a delay is more likely than a rejection.
  2. CFIUS clears with conditions rather than blocking the deal. Data-handling and governance commitments are the more probable outcome than a rejection, based on analyst assessments of the review to date, allowing the transaction to close before or near the September 28 outside date.
  3. BioWare does not shut down outright within the next 12 months, but a sale of the studio or its IP stays on the table. Mark Darrah’s “dormant IP” framing points toward divestiture as financially cleaner than closure – a path that keeps Mass Effect and Dragon Age alive under different ownership even if BioWare itself does not survive intact.
  4. Mass Effect 5’s reception becomes the deciding factor for BioWare’s independence. A well-received launch would be the studio’s first unambiguous win since 2014 and its strongest argument for continued internal investment; a third consecutive miss would leave new, debt-conscious ownership with little reason to keep funding a single-project studio.
  5. Expect tighter monetization and cost discipline across EA’s broader portfolio, not just BioWare. Servicing $20 billion in debt will pressure live-service economies and staffing decisions studio-wide as the new ownership structure takes hold post-close.

The through-line across all five predictions is the same one running through the entire EA buyout: leverage dictates patience, and patience is the one resource a heavily indebted private company has the least of to spare on a struggling prestige studio.

Frequently Asked Questions About BioWare and the EA Buyout

How many people currently work at BioWare?
Fewer than 100 employees, down from more than 400 at the studio’s peak across its Edmonton, Austin, and Montreal offices, and down from over 200 during Dragon Age: The Veilguard’s development. The reduction came through a combination of a January 2025 restructuring and reassignment of staff to other EA projects.

Is Mass Effect 5 still in development?
Yes. The untitled next Mass Effect entry, informally called “Mass Effect 5,” has been in pre-production since early 2025 and is reportedly the sole project occupying BioWare’s remaining staff. No release window has been announced.

Has the EU approved the EA buyout?
The EU’s merger-control (antitrust) review was approved on July 23, 2026. A separate EU Foreign Subsidies Regulation review remains pending, with a decision due by July 30, 2026.

Why does the EU antitrust decision matter for BioWare specifically?
It does not mention BioWare directly, but it removes one of the last major checkpoints before the $55 billion buyout can close and EA takes on roughly $20 billion in debt – the financial pressure industry watchers say is most likely to determine BioWare’s future as a standalone studio.

What happened to Anthem?
Anthem launched in February 2019 to a poor critical and commercial reception. A planned overhaul, “Anthem NEXT,” was canceled in February 2021. EA announced the game would be sunset in July 2025, and its servers went offline for good on January 12, 2026.

How many copies did Dragon Age: The Veilguard sell?
EA has stated sales came in roughly 50% below its internal expectations. The most-cited independent estimate puts lifetime sales under 1.5 million copies, compared with more than 12 million for 2014’s Dragon Age: Inquisition.

Could EA close or sell BioWare?
Neither outcome is confirmed, but former BioWare executive producer Mark Darrah has pointed to EA’s “huge repository of dormant IPs” as evidence that selling a struggling studio or its franchises could be more financially attractive to new ownership than closing it outright.

When will the EA buyout fully close?
No exact date is confirmed. The deal’s US regulatory outside date is September 28, 2026, following an extension from the original June 30 deadline, and closing depends on CFIUS clearance alongside the EU’s pending Foreign Subsidies Regulation decision.

Analysis current as of July 24, 2026. Deal terms, regulatory status, and BioWare staffing figures are based on public filings and reporting; the transaction remains subject to CFIUS review and its September 28, 2026 outside date, and BioWare’s studio-level headcount is not separately disclosed in EA’s public filings. This article is informational and not investment advice.